{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/66db1b74649eda758e10ea12/6900a7cfaee65e114aa6ddba?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Executive Session, Episode 29: Tami Rosen, Cindy Brinkley and Joel Fleming","description":"<p>In this episode of <em>Executive Session</em>, the official podcast of <em>Directors &amp; Boards</em>, we speak with Tami Rosen, director and chief development officer of Pagaya, about what it means for a company to be \"bionic\" when it comes to AI. In our second interview, Cindy Brinkley, director and chair of the human capital (or human resources) committees of Energizer, Ameren and Schnuck Markets, explores the evolution of the human capital committee. And in our final discussion, Joel Fleming, partner with Equity Litigation Group LLP, discusses how boards can uphold their duties of care and loyalty when external guardrails fade.</p>","author_name":"Directors & Boards"}